These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The effect of sodium fluoroacetate and metformin on the antitumor activity of cyclophosphamide on the autochthonous mice sarcoma model]. Anikin IV; Goncharov NV; Tyndyk ML; Voĭshenko NG; Pliss GB; Zabezhinskiĭ MA; Popovich IG; Anisimov VN Vopr Onkol; 2014; 60(4):514-6. PubMed ID: 25552075 [TBL] [Abstract][Full Text] [Related]
4. Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide. Stekar J; Hilgard P; Klenner T Eur J Cancer; 1995; 31A(3):372-4. PubMed ID: 7786605 [TBL] [Abstract][Full Text] [Related]
5. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS]. Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene. Panchenko AV; Fedoros EI; Pigarev SE; Maydin MA; Gubareva EA; Kireeva GS; Tyndyk ML; Kuznetsova AI; Nekhaeva TL; Danilova AB; Baldueva IA; Anisimov VN Integr Cancer Ther; 2019; 18():1534735419833778. PubMed ID: 30841763 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the therapeutic effects of two vanadium complexes administered at low dose on benzo[a]pyrene-induced malignant tumors in rats. Evangelou A; Karkabounas S; Kalpouzos G; Malamas M; Liasko R; Stefanou D; Vlahos AT; Kabanos TA Cancer Lett; 1997 Nov; 119(2):221-5. PubMed ID: 9570375 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513 [TBL] [Abstract][Full Text] [Related]
9. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study of the prophylactic anti-influenza and interferon-inducing activity of epsilon-aminocaproic acid]. Kremerman IB; Priĭmiagi LS; Lozitskiĭ VP; Tefanova VT Antibiot Khimioter; 1988 Jan; 33(1):63-7. PubMed ID: 2454085 [TBL] [Abstract][Full Text] [Related]
11. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo. Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144 [TBL] [Abstract][Full Text] [Related]
13. Acute in vivo resistance in high-dose therapy. Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940 [TBL] [Abstract][Full Text] [Related]
14. L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice. Mehta NR; Wurz GT; Burich RA; Greenberg BE; Griffey S; Gutierrez A; Bell KE; McCall JL; Wolf M; DeGregorio M Clin Cancer Res; 2012 May; 18(10):2861-71. PubMed ID: 22434666 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice. Crispens CG; Sorenson JR In Vivo; 1990; 4(5):321-3. PubMed ID: 2133105 [TBL] [Abstract][Full Text] [Related]
16. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158 [TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor efficacy of antibacterial helvolic acid from Cordyceps taii and cyclophosphamide in a tumor mouse model. Xiao JH; Zhang Y; Liang GY; Liu RM; Li XG; Zhang LT; Chen DX; Zhong JJ Exp Biol Med (Maywood); 2017 Jan; 242(2):214-222. PubMed ID: 27604096 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. Elliott WL; Roberts BJ; Howard CT; Leopold WR Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790 [TBL] [Abstract][Full Text] [Related]
19. Assessment of antitumor activity of BP-C1, a platinum-based anticancer agent with a lignin-derived polymeric ligand, in autochthonous induced and spontaneous carcinogenesis rodent models. Fedoros EI; Tyndyk ML; Popovich IG; Anikin IV; Yurova MN; Gubareva EA; Pigarev SE; Panchenko AV; Solovyev ND; Anisimov VN J Trace Elem Med Biol; 2022 Sep; 73():127013. PubMed ID: 35679766 [TBL] [Abstract][Full Text] [Related]
20. Cicaprost does not affect tumor inhibitory potential of cytostatic drugs. Schirner M; Schneider M Anticancer Res; 1993; 13(3):743-6. PubMed ID: 8317906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]